4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-003525
Director acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP Director | 2023-01-12 | Option exercise | +15,000 | $5.22 | $78,300 | 3,521,613 | I |
| BAKER BROS. ADVISORS LP Director | 2023-01-12 | Option exercise | +15,000 | $5.22 | $78,300 | 38,484,981 | I |
| Derivatives | |||||||
| BAKER BROS. ADVISORS LP Director | 2023-01-12 | Option exercise · Non-Qualified Stock Options (right to buy) | −15,000 | 0 | I | ||
| BAKER BROS. ADVISORS LP Director | 2023-01-12 | Option exercise · Non-Qualified Stock Options (right to buy) | −15,000 | 0 | I | ||
Loading xslF345X03/doc4.xml…